Gerardo Altamura

Gerardo Altamura


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 May 2023 in Archives of Public Health
Verified
Journal Article
Open access
PDF file
MNMario Cesare Nurchis
Mario Cesare Nurchis
GAGerardo Altamura
Gerardo Altamura
MRMaria Teresa Riccardi
Maria Teresa Riccardi
FRFrancesca Clementina Radio
Francesca Clementina Radio
GCGiovanni Chillemi
Giovanni Chillemi
GDGianfranco Damiani
Gianfranco Damiani
Background: About 80% of the roughly 7,000 known rare diseases are single gene disorders, about 85% of which are ultra-rare, affecting less than one in one million individuals. NGS technologies, in particular whole genome sequencing (WGS) in paediatric patients suffering from severe disorders of likely genetic origin improve the diagnostic yield allowing targeted, effective care and management. The aim of this study is to perform a systematic review and meta-analysis to assess the effectiveness of WGS, with respect to whole exome sequencing (WES) and/or usual care, for the diagnosis of suspected genetic disorders among the paediatric population.Methods: A systematic review of the literature was conducted querying relevant electronic databases, including MEDLINE, EMBASE, ISI Web of Science, and Scopus from January 2010 to June 2022. A random-effect meta-analysis was run to inspect the diagnostic yield of different techniques. A network meta-analysis was also performed to directly assess the comparison between WGS and WES.Results: Of the 4,927 initially retrieved articles, thirty-nine met the inclusion criteria. Overall results highlighted a significantly higher pooled diagnostic yield for WGS, 38.6% (95% CI: [32.6 – 45.0]), in respect to WES, 37.8% (95% CI: [32.9 – 42.9]) and usual care, 7.8% (95% CI: [4.4 – 13.2]). The meta-regression output suggested a higher diagnostic yield of the WGS compared to WES after controlling for the type of disease (monogenic vs non-monogenic), with a tendency to better diagnostic performances for Mendelian diseases. The network meta-analysis showed a higher diagnostic yield for WGS compared to WES (OR = 1.54, 95%CI: [1.11 – 2.12]).Conclusions: Although whole genome sequencing for the paediatric population with suspected genetic disorders provided an accurate and early genetic diagnosis in a high proportion of cases, further research is needed for evaluating costs, effectiveness, and cost-effectiveness of WGS and achieving an informed decision-making process.Trial Registration: This systematic review has not been registered.

23 March 2023 in BMJ Open
Verified
Journal Article
Open access
PDF file
GDGianfranco Damiani
Gianfranco Damiani
GAGerardo Altamura
Gerardo Altamura
MZMassimo Zedda
Massimo Zedda
MNMario Cesare Nurchis
Mario Cesare Nurchis
GAGiovanni Aulino
Giovanni Aulino
AOAntonio Oliva
Antonio Oliva
Objectives The aim of this study is to investigate the effect of artificial intelligence (AI) and/or algorithms on drug management in primary care settings comparing AI and/or algorithms with standard clinical practice. Second, we evaluated what is the most frequently reported type of medication error and the most used AI machine type. Methods A systematic review of literature was conducted querying PubMed, Cochrane and ISI Web of Science until November 2021. The search strategy and the study selection were conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses and the Population, Intervention, Comparator, Outcome framework. Specifically, the Population chosen was general population of all ages (ie, including paediatric patients) in primary care settings (ie, home setting, ambulatory and nursery homes); the Intervention considered was the analysis AI and/or algorithms (ie, intelligent programs or software) application in primary care for reducing medications errors, the Comparator was the general practice and, lastly, the Outcome was the reduction of preventable medication errors (eg, overprescribing, inappropriate medication, drug interaction, risk of injury, dosing errors or in an increase in adherence to therapy). The methodological quality of included studies was appraised adopting the Quality Assessment of Controlled Intervention Studies of the National Institute of Health for randomised controlled trials. Results Studies reported in different ways the effective reduction of medication error. Ten out of 14 included studies, corresponding to 71% of articles, reported a reduction of medication errors, supporting the hypothesis that AI is an important tool for patient safety. Conclusion This study highlights how a proper application of AI in primary care is possible, since it provides an important tool to support the physician with drug management in non-hospital environments.

Jacopo GarlascoJacopo Garlasco
Jacopo Garlasco
MNMario Cesare Nurchis
Mario Cesare Nurchis
VBvalerio bordino
valerio bordino
MSMartina Sapienza
Martina Sapienza
GAGerardo Altamura
Gerardo Altamura
MGMaria Michela Gianino
Maria Michela Gianino
Cancers currently represent a leading cause of morbidity and mortality, and precisely estimating their burden is crucial for evidence-based decision-making. This study aimed at understanding the average costs of cancer-related disability-adjusted life years (DALYs) and highlighting possible differences in economic estimates obtained with diverse approaches. We searched four scientific databases to identify all the primary literature simultaneously investigating cancer-related costs and DALYs. In view of the different methodologies, studies were divided into two groups: those estimating costs starting from DALYs, and those independently performing cost and DALY analyses. The latter were pooled to compute costs per disease-related DALY: meta-analytic syntheses were performed for total costs and indirect costs, and in relation to the corresponding gross domestic product (GDP) per capita. The quality of included studies was assessed through the Quality of Health Economic Studies instrument. Seven studies were selected. Total and indirect pooled costs per DALY were, respectively, USD 9150 (95% CI: 5560–15,050) and USD 3890 (95% CI: 2570–5880). Moreover, the cost per cancer-related DALY has been found to be, on average, 32% (95% CI: 24–42%) of the corresponding countries’ GDP per capita. Costs calculated a priori from DALYs may lead to results widely different from those obtained after data retrieval and model building. Further research is needed to better estimate the economic burden of cancer in terms of costs and DALYs.

16 September 2022 in Frontiers in Digital Health
Verified
Journal Article
Open access
FCFidelia Cascini
Fidelia Cascini
GAGerardo Altamura
Gerardo Altamura
GFGiovanna Failla
Giovanna Failla
AGAndrea Gentili
Andrea Gentili
VPValeria Puleo
Valeria Puleo
WRWalter Ricciardi
Walter Ricciardi
Background: To promote shared digital health best practices in a global context, as agreed within the Global Digital Health Partnership (GDHP), one of the most important topics to evaluate is the ability to detect what participating countries believe to be priorities suitable to improve their healthcare systems. No previously published scientific papers investigated these aspects as a cross-country comparison.Objective: The aim of this paper is to present results concerning the priorities identification section of the Evidence and Evaluation survey addressed to GDHP members in 2021, comparing countries’ initiatives and perspectives for the future of digital health based on internationally agreed developments.Methods: This survey followed a cross-sectional study approach. An online survey was addressed to the stakeholders of 29 major countries.Results: Ten out of 29 countries answered the survey. The mean global score of 3.54 out of 5, calculated on the whole data set, demonstrates how the global attention to a digital evolution in health is shared by most of the evaluated countries.Conclusion: The resulting insights on the differences between digital health priority identification among different GDHP countries serves as a starting point to coordinate further progress on digital health worldwide and foster evidence-based collaboration.

3 June 2024 in Social Indicators Research
Verified
Journal Article
Open access
PDF file
IVIlaria Valentini
Ilaria Valentini
MNMario Cesare Nurchis
Mario Cesare Nurchis
GAGerardo Altamura
Gerardo Altamura
ACAmerico Cicchetti
Americo Cicchetti
GDGianfranco Damiani
Gianfranco Damiani
GAGiuseppe Arbia
Giuseppe Arbia
This study examines spatial disparities and associations between the social deprivation index (SDI) and Type 2 Diabetes, Dementia, and Heart Failure in Italy’s Lazio Region. The primary goal is to assess how social deprivation impacts health inequalities by analysing SDI-disease correlations. This retrospective study uses 2020 socioeconomic data and 2021 epidemiological indicators in Lazio Region, Italy. The SDI, constructed following established guidelines, measures social deprivation. Statistical tools, including regression models, Moran’s I test, and LISA techniques, are used to analyse spatial patterns. Utilizing a retrospective approach, we merge 2020 socioeconomic and 2021 epidemiological data for analysis. The SDI is computed using established methods. Spatial disparities are explored through regression models, Moran’s I test, and LISA techniques. The study reveals significant disparities in disease incidence. District V in Rome exhibits high Type 2 Diabetes (113.75/1000) and Heart Failure (37.98/1000) rates, while Marcetelli has elevated Dementia incidence (19.74). Southern municipalities face high unemployment (up to 25%), whereas bordering areas have higher education levels (30–60%). Disease hotspots emerge in Rome and centre-north municipalities, aligning with social deprivation patterns. Regression models confirm the link between disease incidence and socioeconomic indicators. SDI ranges from − 1.31 to + 10.01. This study underscores a correlation between social deprivation and disease incidence. Further national-level research is essential to deepen our understanding of how social deprivation influences health outcomes, with potential implications for addressing health disparities both regionally and nationally.

FBFlavia Beccia
Flavia Beccia
GAGiovanni Aulino
Giovanni Aulino
CACarlotta Amantea
Carlotta Amantea
ALAlberto Lontano
Alberto Lontano
GAGerardo Altamura
Gerardo Altamura
PLPatrizia Laurenti
Patrizia Laurenti
To maintain safety conditions in the provision of care and assistance, and to protect healthcare workers (HCWs) and patients, the Italian government required compulsory COVID-19 vaccination for HCWs, including medical residents (MRs). The aim of this study was to assess COVID-19 vaccination coverage in MRs in a large tertiary hospital in Italy, before and after the introduction of compulsory vaccination, according to demographic characteristics and specific residency. A database on COVID-19 vaccination status and infection of resident medical doctors was created. Descriptive statistics and logistic regressions were carried out on the data. A total of 1894 MRs were included in the study. Being vaccinated in the same hospital as the residency program was significantly related to the year of residency and being enrolled in a frontline residency. A significant association between compliance with the compulsory primary cycle vaccination and vaccination in the hospital residency was observed. Being enrolled in the second, third, and last years of residency, and in a frontline residency, were predictive of being vaccinated in the residency hospital. Almost 100% of the MRs participating in the study were vaccinated against COVID-19. Compulsory vaccination of HCWs, alongside greater and clearer information about the risks and benefits of vaccination, represents an important booster to ensure public health and to promote quality and safety of care.
1